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Molecular  mechanisms  guiding  naïve  T helper  cell  differentiation  into  functionally  speciﬁed  effector  cells
are  intensively  studied.  The  rapidly  growing  knowledge  is  mainly  achieved  by using  mouse  cells  or disease
models.  Comparatively  exiguous  data is  gathered  from  human  primary  cells  although  they  provide  the
“ultimate model”  for  immunology  in  man,  have  been  exploited  in  many  original  studies  paving  the  way
for the  ﬁeld,  and  can  be analyzed  more  easily  than  ever  with  the  help  of modern  technology  and  methods.
As usage  of  mouse  models  is  unavoidable  in translational  research,  parallel  human  and  mouse  studies
should  be performed  to  assure  the  relevancy  of  the  hypothesis  created  during  the  basic  research.  In  this
review,  we  give  an  overview  on  the  status  of the  studies  conducted  with  human  primary  cells  aiming
at elucidating  the  mechanisms  instructing  the  priming  of  T  helper  cell  subtypes.  The  special  emphasis
is  given  to the  recent  high-throughput  studies.  In addition,  by  comparing  the  human  and  mouse  studies
we  intend  to  point  out the  regulatory  mechanisms  and  questions  which  are  lacking  examination  with
 201
human  primary  cells.
. Introduction
Characterization of signaling pathways and biomedical research
elies heavily on experiments done with mouse models. However,
ailures in translational research are regrettably common [1,2].
he experimental setups for basic research and clinical trials
ay  differ from each other and the disease models may  be over-
impliﬁed [1–4]. Moreover, there may  be signiﬁcant biological
ifferences between the experimental animals and human [5,6],
hich could explain the unsatisfactory success rate in introducing
ew therapeutic interventions onto the market. To address these
uestions, the beneﬁts and the limitations of experimental models
eed to be evaluated by comparing the molecular networks across
pecies. Recently published comparison of immunologic responses
Abbreviations: ChIA-PET, chromatin interaction analysis by paired-end tag
equencing; ChIP, chromatin immunoprecipitation; ChIP-seq, chromatin immuno-
recipitation coupled to high-throughput sequencing; iTreg, inducible T regulatory
ell,  adaptive T regulatory; lincRNA, long intergenic non-coding RNA; lncRNA,
ong non-coding RNA; miRNA, microRNA; RNAi, RNA interference; RNA-seq, high-
hroughput RNA sequencing; siRNA, short interfering RNA; SNP, single nucleotide
olymorphism; STAT, signal transducer and activator of transcription; TCR, T cell
eceptor; Tfh, follicular T helper cell; Th, T helper cell; UTR, untranslated region of
RNA.      
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 2013 The Author. Published by Elsevier Ltd. Open access under CC BY-NC-ND lbetween human inﬂammatory disease and the corresponding
mouse models revealed both species-speciﬁc and model-speciﬁc
discrepancies [7]. Mouse models have been extensively used also
in characterization of signaling driving T helper (Th) cell differen-
tiation. Th cells are orchestrators of immune responses working in
between the innate and adaptive immunity. Their momentous role
is most dramatically evidenced by fatal susceptibility of subjects
with AIDS to opportunistic infections and cancer due to dramatic
loss of Th cell pool. Unsuccessful dampening of Th cell activity can
on the other hand lead to several inﬂammatory or autoimmune
diseases.
Cells of the innate immune system express different cytokines
and co-receptors in response to intrinsic features of a pathogen.
The cytokine milieu along with the strength of T cell receptor (TCR)
crosslinking and engagement of co-receptors delineate the differ-
entiation path, which naïve Th cell will take. As different Th cell
subtypes have varying cytokine expression proﬁles and homing
preferences they trigger a unique immune response needed for
speciﬁc elimination of the intruding pathogens. Originally, two
opposite Th cell phenotypes were described and named as Th1
and Th2 cells either targeting intra- or extracellular pathogens,
respectively [8,9]. Th1 cells produce high amounts of IFN [8,9],
and defects in Th1 cell signaling are associated with susceptibility
to Salmonella and mycobacterial infections [10]. Th2 cells express
IL4, IL5 and IL13 genes [8,9] clustered to chromosome 5 in human.
Th2 cells are known to control parasite infections, but are also acti-
3 The Author. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.vated in response to a variety of other stimuli [11]. Although this
simplistic Th1/Th2-distinction has been a powerful model, it has
been replaced during the recent years with a more extensive and
ﬂexible view on Th cell differentiation and function. The family of
icense.
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h cells has been expanded to include iTreg (inducible T regulatory,
daptive T regulatory Th cells), Tfh (follicular Th cells,) Th9, Th17
nd Th22 cell subsets, and the plasticity between the phenotypes
s intensively studied [12].
iTreg cells, generated in periphery, are needed to complement
he suppressive function of thymus-derived natural Treg cells
13,14]. Speciﬁc differentiation of this subset was  suggested to
appen in human [15], but it has remained controversial whether
he cells with TGF1-inducible FOXP3 expression have suppres-
ive function [16]. However, addition of IL2 and retinoic acid to
he culturing medium and more recently inhibition of anaphyla-
oxin signaling through complement C3a and C5a receptors have
or example been reported to increase the suppressive competence
f iTreg cells in human [17,18]. Tfh cells, identiﬁed from tonsil-
ar samples and shown to express CXCR5 [19,20], are required for
he formation of germinal centers and production of high-afﬁnity
ntibodies [21]. IL9-producing Th9 cells were identiﬁed in human
hortly after corresponding mouse studies [22,23]. In contrast to
ouse studies, the in vivo existence of human Th9 cells has been
hown both in healthy individuals and associated with inﬂamma-
ion [24]. The precise role of Th9 cells in the immune system is
till ill-deﬁned, but it is expected to overlap with the function of
h2 cells. In human also a Th22 subset that secretes IL22 but not
ytokines characteristic for other Th cell subsets has been reported
25–27]. Moreover, some studies indicate that there is a similar
ellular phenotype, namely cells able to secrete IL22 but not IL17,
lso in mice [28–30]. Skin-inﬁltrating Th22 cells have been sug-
ested to play a role in maintaining epidermal integrity [25–27]. In
ontrast to Th9 and Th22 cells, which have not yet been completely
pproved as separate Th cell lineages, Th17 cells have a strong posi-
ion in the Th cell family. In human, IL17 and IL17F secreting Th17
ells were identiﬁed from gut tissue of patients with Crohn’s disease
nd from peripheral blood [31–33] and were the ones initiating the
omenclature based on the archetypical cytokine secreted by the
ubset. Th17 cells induce an immunological response needed for
radication of extracellular bacterial and fungal infections [34].
Two in vitro models are used to study human Th cell priming;
olarization of either umbilical cord blood or peripheral blood-
erived naïve CD4+ cells. Cord blood CD4+ cells are mainly naïve by
ature [35], but the proportion of naïve cells decreases in periph-
ral blood as a function of age [36]. Priming of Th cell subtypes
rom naïve CD4+ cells from both of these sources has similar
equirements, but also clear differences in their activation and
ifferentiation have been reported [37–40]. Compared to exper-
ments performed with mouse cells, additional challenge with
uman primary cells is genetic heterogeneity leading to variation
n responses. Depending on the question this can be handled by
nalyzing cells from several individuals side-by-side or by pooling
he cells to detect average response.
The aim of this review is to summarize mechanisms which are
nown to affect gene expression during Th cell differentiation, and
o point out cellular regulatory systems whose contribution has not
et been deﬁned in this ﬁeld (Fig. 1). We  focus in particularly on the
nitiation of human Th cell subtype development. In addition, due
o a limited space the special emphasis is given to high-throughput
arge-scale studies. To guide readers to more detailed mechanistic
tudies and a wider variety of original observations, we  aim at citing
he most relevant review articles.
.1. Transcriptional regulation of human Th cell priming
Integration of external stimuli from cytokines along with
rosslinking of TCR and co-receptors in the immunological synapse
pon recognition of cognate antigen leads to activation and ini-
iation of functional maturation of naïve Th cell. One of the
riteria used to identify different Th cell subsets has been thatmmunology 25 (2013) 282– 290 283
their differentiation is driven by quintessential transcription fac-
tors which get activated by a speciﬁc cytokine or combination of
cytokines. Members of the STAT (signal transducer and activator
of transcription) family are expressed already in naïve Th cells and
are promptly activated by cytokine stimulus-speciﬁc phosphoryla-
tion. STATs synergistically with TCR-activated transcription factors
direct the transcriptional regulation of inducible master regulators.
Consequently, all Th cell subsets can be identiﬁed from each other
based on their distinct transcriptional proﬁles [25,41–46]. Com-
pared to the Th cell subtype-delineating transcriptional proﬁles,
TCR crosslinking alone causes much more extensive changes in
the gene expression both qualitatively and quantitatively [43,47].
Thus it is important to analyze not only the Th cell subtype-speciﬁc
expression patterns, but also to interpret these in the context of all
factors present in the cell. Current microarray and RNA-seq appli-
cations can capture global snapshot of the expression of transcripts
within the cell population. Thus our view on putative regulators of
Th cell differentiation has expanded from few candidate genes to
hundreds of genes working in a combinatorial and competitive way.
The evolution of the understanding of the global view on the human
Th cell transcriptome is evident for example from our studies char-
acterizing the initiation of human Th1 and Th2 cell polarization.
The pilot study on cord blood cells polarized toward Th1 and Th2
phenotype resulted in identiﬁcation of less than hundred genes
speciﬁcally expressed in either subtype [43]. The follow up exper-
iments with the improved array platforms increased the number
of differentially regulated genes several fold [48,49]. Technological
improvements have also made it possible to analyze gene expres-
sion more cost-efﬁciently than ever. This has further broadened our
view on the Th cell differentiation by making kinetic analysis more
feasible. Through proﬁling of human Th2 cell priming altogether
at nine timepoints between 0.5 and 72 h, we identiﬁed more than
thousand genes to be differentially regulated in response to IL4, and
illustrated how dynamic the process is [41]. The same approach was
also shortly used to characterize human Th1 and Th17 cell priming
[42,44]. Implementation and development of robust computational
methods [42,50,51] facilitate efﬁcient data mining of these impres-
sive datasets to improve understanding of the principles of human
Th cell priming. It is also worth of applying novel methods to further
analyze the older datasets. For instance, reanalysis of our Th2 cell
data which was gathered under TGF-modulated differentiation
[43] and interpretation of the results in the light of current knowl-
edge of Th cell subtypes lead to identiﬁcation of the ﬁrst human
“Th9” cell transcriptome [47], although the polarization conditions
might not have been the most optimal [37]. Global proﬁling meth-
ods should also be used to characterize heterogeneity and plasticity
of Th cell phenotypes, as it has become obvious that interpretations
cannot be based solely on expression of key transcription factors or
cytokines [52].
Discovery of RNA interference (RNAi) and harnessing it to
the beneﬁt of studies on human Th cells [53] have greatly
empowered characterization of transcriptional regulation. Our
group has exploited RNAi to identify target genes of several fac-
tors involved in human Th cell polarization; ATF3 [54], PIM kinases
[55], PRELI [56], SATB1 [57] and most intensively STAT6 [41,49].
Combined to gene regulation studies chromatin immunoprecipi-
tation (ChIP) analyses are indispensable for discrimination of direct
and secondary target genes. In our study on the role of STAT6 in
human Th2 cell priming, we  observed that over 80% of the IL4-
regulated genes were controlled by STAT6 [41]. The magnitude
of the effect of STAT6-siRNA was  the strongest among the IL4-
inducible genes, suggesting that STAT6 is primarily needed for
driving the subtype-speciﬁc transcriptional changes. In addition by
using ChIP-seq, we  further demonstrated that around 30% of the
STAT6-regulated genes were under a direct control of this factor
and formed the core of STAT6-mediated signaling [41]. However,
284 S. Tuomela, R. Lahesmaa / Seminars in Immunology 25 (2013) 282– 290
Fig. 1. Mechanisms of gene expression regulation discussed in this article. Extracellular signals provided by tissue environment and antigen presenting cells in a form of
cytokines, and crosslinking of antigen and co-receptors are integrated into instructions for Th cell differentiation. Polarized Th cells have their speciﬁc function and tissue
localization depending on their cytokine secretion and homing receptor expression pattern. The differentiation is regulated at all levels of gene expression out of which
transcription, RNA processing and epigenetics are covered in this review. The regulatory mechanisms are interconnected, form feedback circuitries and control plasticity
of  Th cell phenotypes. Key open questions for future studies include for example analysis of extent and mechanisms of collaboration between transcription regulators,
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ntegration and ﬂexibility of different regulatory mechanisms.
NAi-mediated downregulation has its limitations. For example,
chieving a long-lasting downregulation of highly inducible target
enes or downregulation of target genes at a speciﬁc time point
uring primary Th cell differentiation is challenging. In addition,
ilencing several genes simultaneously might lead to exhaustion
f the endogenous RNAi machinery resulting in unspeciﬁc effects
58]. Thus, further development and exploitation of novel techni-
al improvements, such as silicon nanowire-based introduction of
iRNAs efﬁciently used with mouse unstimulated primary Th cells
59] are extremely important for mechanistic studies.There are several genome-wide studies on transcriptional pro-
ling of T helper cell subtypes and identiﬁcation of target genes of
arious transcription factors in mouse. However, there is a striking
ack of such human studies (Table 1). In addition, the differences and non-coding RNAs, mechanisms involved in long-distance gene regulation, and
in experimental design of the human and mouse studies avail-
able rarely allow direct unambiguous comparison of the results.
For example, STAT6 target genes have been assessed from polar-
ized Th2 cells after restimulation or at the initiation of polarization
process in mouse and human, respectively [41,60]. Beyond the lim-
itations due to the experimental layout, it is of interest that there
are genes which are either bound by STAT6 or regulated by STAT6
both in human and mouse. This indicates that STAT6 is needed both
for initiation and enhancement of Th2 cell polarization. Especially,
factors involved in the control of transcription are often regu-
lated by STAT6 in human and mouse (Laurila et al., unpublished).
Multiparametric experimental approaches are needed to further
elucidate the transcriptional programs resulting in Th cell speciﬁ-
cation as factors do not work in isolation, but co-operate through
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Table 1
Selected original and combinatorial high-throughput analysis of direct target genes of CD4+ cell differentiation master regulators and histone modiﬁcations in mouse, and studies performed with human primary cells.
Mouse Human
Marker Cytokine stimulus Methods Ref. Marker Cytokine stimulus Methods Ref.
Th1
STAT4, STAT5A, STAT5B IL12 ChIP-seqa [125] STAT1 IFNg ChIP-seq [125]
GATA3 IL12 + IL2 ChIP-seq + RNA-seqb [80] STAT4 IL12 ChIP-seq [125]
H3K4me3, H3K27me3 IL12 + IL2 ChIP-seq + RNA-seq [76] TBX21, GATA3 IL12 ChIP-chiph + Exp. array [64]
TBX21; H3K4me1, H3K27me3 (WT  and
Tbx21−/−)
IL12 + IL2 ChIP-seq + RNA-seq [85] TBX21, GATA3 IL12 ChIP-seq [63]
TBX21; H3K4me3, H3K36me3 (WT  and
Tbx21−/−)
IL12 ChIP-seq, DHS-seqc [84] H3K4me1, H3K4me3, H3K27ac, CTCF IL12 ChIP-seq + RNA-seq [75]
STAT4; H3K4me3, H3K27me3, H3K36me3 (WT
and Stat4−/−)
IL12 ChIP-seq + Exp. arrayd [60]
DNA methylation, H3K4me3, H2K27me3 IL12 + IL2 MAP-seqe + ChIP-seq + Exp. array [126]
STAT1; p300 (WT, Stat1−/−, Stat4−/−,
Tbx21−/−,  Tbx21 oef; Stat4−/− and Tbx21
oe); H3K4me1 (WT, Stat1−/−, Stat4−/−,
Tbx21−/−)
IL12 ChIP-seq + RNA-seq [79]
Th2
STAT5A, STAT5B IL2 ChIP-seq [125] STAT5A, STAT5B IL2 ChIP-seq [125]
STAT5A, STAT5B IL4 ChIP-seq [127] STAT6 IL4 ChIP-seq + Exp. array [41]
STAT6; H3K4me3, H3K27me3, H3K36me3 (WT
and Stat6−/−)
IL4 ChIP-seq + Exp. array [60] GATA3, TBX21 IL4 ChIP-chip + Exp. array [64]
GATA3, FLI1, ETS1; H3K4me1, H3K4me2,
H3K4me3, H3K27me3; H3K4me2 and
H3K27me3 (WT  and Gata3−/−)
IL4 + IL2 ChIP-seq + RNA-seq [80] GATA3 IL4 ChIP-seq [63]
DNA methylation IL4 + IL2 MAP-seq + Exp. array [126] H3K4me1, H3K4me3, H3K27ac, CTCF IL4 ChIP-seq + RNA-seq [75]
p300 (WT, Stat6−/−, Gata3 oe; Stat6−/− and
Gata3 oe); H3K4me1 (WT  and Stat6−/−)
IL4 ChIP-seq + RNA-seq [79]
Th17
GATA3 TGFb + IL6 + IL1b ChIP-seq + RNA-seq [80]
H3K4me3, H3K27me3 TGFb + IL6 + IL1b ChIP-seq + RNA-seq [76]
STAT3, STAT5 TGFb + IL6 ChIP-seq + Exp. array [128]
pSTAT3; H3K4me3 (WT  and Stat3−/−) TGFb + IL6 ChIP-seq + Exp. array [78]
STAT3, IRF4, BATF, c-Maf, RORg, FOSL2, ETV6,
HIF1a, CTCF; p300 (WT, Irf4−/−, Batf−/− and
Stat3−/−); p300, H3K4me2, H3K4me3 (WT
and RORg−/−)
TGFb + IL6 ChIP-seq + RNA-seq + FAIRE-seqg [62]
iTreg
GATA3 TGFb + IL2 ChIP-seq + RNA-seq [80]
H3K4me3, H3K27me3 TGFb + IL2 ChIP-seq + RNA-seq [76]
Tfh
H3K4me3, H3K27me3 IL6 + IL21 ChIP-seq + Exp. array [77]
a ChIP-seq, chromatin immunoprecipitation coupled to high-throughput sequencing.
b RNA-seq, high-throughput RNA sequencing.
c DHS-seq, DNase hypersensitivity analysis coupled to high-throughput sequencing.
d Exp. array, expression array proﬁling.
e MAP-seq, methyl-binding domain afﬁnity puriﬁcation coupled to high-throughput sequencing.
f oe, over-expression
g FAIRE-seq, formaldehyde-assisted isolation of regulatory elements based on open chromatin structure coupled to high-throughput sequencing.
h ChIP-chip, chromatin immunoprecipitation coupled to microarray analysis.
Some of the above mentioned studies contain combinatorial analysis of binding sites of several transcription factors, or epigenetic modiﬁcations and transcription factor binding data which are not speciﬁed in this table due to
simplicity. Please refer to the original publications for further experimental details.
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everal mechanisms. Even so called master regulators can be found
xpressed together in the same cell [61]. Recent mouse studies have
mpressively reconstructed the transcription factor hierarchy and
nterplay during Th17 cell differentiation by integrating data from
erturbed expression of various genes to time-series mRNA mea-
urements and DNA binding data [59,62]. Parallel analysis of GATA3
nd TBX21 binding patterns in human Th1 and Th2 polarized cells
emonstrated that these factors could bind to distinct as well as
ame genomic regions, and that TBX21 directs the redistribution of
ATA3 binding sites to suppress Th2 cell polarizing signaling in Th1
ells [63,64]. Such integrated analyses with parallel modiﬁcation of
xpression of several genes along with identiﬁcation of nucleic acid
nd protein binding partners on human cells would greatly increase
ur understanding on the principles of Th cell polarization.
.2. Epigenetic regulation of Th cell priming in human
Biochemical modiﬁcations of the DNA and histones, and chro-
atin conformation form the genetic landscape for transcriptional
egulators. These heritable changes are collectively called epige-
etic to discern them from the ones affected by alterations in the
NA sequence. Targeted analysis of cytokine loci demonstrated the
ole of epigenetic mechanisms in Th cell differentiation [65]. Since
hese ﬁrst studies validating the concept, the view on overall mag-
itude of changes in epigenetic patterns has been expanded with
he help of technical improvements, especially the ones enabling
ast sequencing [66]. The increased knowledge of epigenetic reg-
lation has also revealed novel functions for intergenic regions
f our genome, the sequences once thought to be only “junk”
NA. Characterization of different cell types and responses to a
ange of environmental signals has uncovered that non-coding DNA
tretches serve important roles for example as enhancers, insu-
ators or nuclear organizers. Non-coding regions harbor several
ingle nucleotide polymorphisms (SNPs) associated with human
iseases [67]. The linkage between epigenetic regulation and dis-
rders manifesting unbalanced Th cell activity is an exciting area
or future research [68,69].
Patterns of methylation and acetylation modiﬁcations of his-
ones, nucleosome positioning and accessibility of chromatin have
een studied and correlated with gene expression in human periph-
ral blood CD4+ T cells before or after activation [70–73]. Human
reg lineage-speciﬁc DNA methylation map  indicated cell type-
peciﬁc enhancer activity [74]. In addition to these studies, there
s only one recent report on genome-wide epigenetic patterns in
uman CD4+ cells. This study demonstrated that linage-speciﬁc
nhancers become active already at early stages of human Th
ell differentiation [75]. The lack of epigenetic data related to
uman primary CD4+ cell differentiation is in sharp contrasts with
he numerous genome-wide datasets gathered from mouse cells
Table 1). In mouse, maps of active (H3K4me3) and repressed sites
H3K27me3) have been reported in Th1, Th2, Th17, iTreg, nTreg and
fh cells [76,77]. In addition, analysis of the role of master regulators
f Th cell differentiation has shown that STAT3, STAT4, STAT6 and
ATA3 regulate the speciﬁcity of histone modiﬁcations deﬁning
nhancers, active or repressed sites [60,62,76,78–80]. Instead, the
tudies on enhancers in Th1, Th17 and Treg cells have revealed that
he role of TBX21, RORt and FOXP3 is much more limited, respec-
ively [62,79,81]. However, different analysis integrating human
nd mouse datasets suggested that TBX21, similarly to GATA3,
egulates especially its immunologically relevant target genes via
istal regulatory sites having enhancer or insulator properties [63].
n conclusion, in the light of current knowledge STATs appear to
e the main architects of establishing Th subtype-speciﬁc epige-
etic landscape and the lineage-delineated transcription factors are
esponsible for further ﬁne-tuning. However, STATs work in the
ontext of TCR stimulation-activated factors, which are importantmmunology 25 (2013) 282– 290
pioneering factors creating epigenetic landscape enabling Th cell
polarization [61,82].
Already at the very early steps of Th cell differentiation process,
at 3 days after the initiation of polarization, Th cell lineage-
speciﬁc epigenetic marks can be found in human [75]. While
at this time cells have just started to proliferate, they already
have their lineage-speciﬁc transcriptional proﬁles. The number
of Th1 and Th2 cell-speciﬁc enhancers at this is time was at
the level of two  thousand. Majority of the enhancers were at
the poised state, as deﬁned by H3K4me1 without co-localizing
H3K27ac mark, indicating that cells are ready to respond to
environmental signals corresponding to their speciﬁc genomic
landscape. Importantly, around 30% of the Th1 or Th2 cell-speciﬁc
enhancers were already active. DNA motif discovery revealed
that many predicted enhancers contained putative binding sites
for Th1 or Th2 cell-speciﬁc transcription factors such as STAT1,
STAT4, STAT6 or GATA3. In addition, several predicted enhancers
harbored SNPs associated with immune-mediated diseases [75].
In mouse STAT6 has been reported to regulate a great major-
ity of the active enhancers (p300 and H3K4me1 double positive
sites) after restimulation of in vitro polarized Th2 cells, part of
this control being also direct as evidenced by chromatin binding
[79]. When the STAT6 binding sites reported in human [41] and
Th2 cell enhancer map  [75] are overlaid, a statistically signiﬁcant
(p < 0.001) overlap can be found both when the Th2 cell-speciﬁc,
or all enhancers found in Th2 cells are compared. Based on this
analysis there are tens of enhancers at which STAT6 binding and
enhancer marks have colocalization of at least 100 nucleotides
(Larjo et al., unpublished). However, as the activity of enhancers
is known to be sensitive indicator of cell identity and differentia-
tion process [83], to address the role of STAT6 in enhancer-directed
gene expression regulation in human requires experiments where
all measurements are performed on samples collected at the same
time points. The causal relationship between the DNA binding of
key transcription factors for Th cell differentiation and regulation
of epigenetic marks should be further investigated in human as
already reported with transcription factor-deﬁcient mice (Table 1)
[60,62,77–80,84,85].
Looping of the distal regulatory sites into juxtaposed confor-
mation coordinates expression of Il4,  Il5 and Il13 within the Th2
cytokine locus [86,87]. In addition, Ifn  and Th2 cytokine loci form
a high-order interchromosomal interaction, which holds the genes
in an inactive state until activation of transcription of Th1 or Th2
cell-speciﬁc signature cytokine [88]. The regulation of chromatin
conformation within the Th2 cytokine loci has been reported to be
under the control of STAT6, GATA3 and SATB1 [86,87]. In human
SATB1 has been highlighted to be important in repressing the
expression of IL5 during the priming of Th2 cells by competing the
action of GATA3 [57]. This initial observation was  followed by char-
acterization of the role of SATB1 comprehensively in a wider variety
of CD4+ cell differentiation programs leading to the identiﬁcation
of SATB1 as a gate-keeper of T effector cell transcriptional pro-
grams over the FOXP3-induced regulatory Treg phenotype [89]. In
Treg cells overexpression of SATB1 resulted in induction of several
genes associated with Th1, Th2 and Th17 cells, and these cells lost
their suppressive function. Thus SATB1 plays an important role in
developmental decision between T regulatory and T effector cells,
but also ﬁne-tunes Th cell differentiation programs [57,89]. It has
not been studied whether reorganization of chromatin structures
is involved in SATB1-mediated conversion of Treg cells into effec-
tor cells. Likewise, studies exploiting chromosome conformation
assays to elucidate human Th cell differentiation have not been
reported. Interestingly, structural analysis of GATA3 and FOXP3
indicate that for example these two  proteins important for Th cell
differentiation have an ability to bridge DNA  sequences together
and thus enable intra- or interchromosomal interactions [90,91].
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.3. Regulation of Th cell differentiation by RNA processing and
on-coding RNAs
ENCODE project reported that three-quarters of the human
enome is being transcribed [92]. RNA molecules which originally
ere thought to serve only as messengers or structural components
n translation have since then got a range of novel functions and
egulatory mechanisms associated with them. Genes are known to
roduce several different isoforms as a result of alternative splic-
ng [92]. Validation of the alternative splicing events observed in
olyclonally activated Jurkat cells conﬁrmed that isoform ratios
hange also in human primary CD4+ cells upon activation [93].
nterestingly, among the genes validated to have changes in exon
nclusion rates were GATA3 and HIF1  ˛ [93] known to contribute to
h2 and Th17 cell phenotype, respectively [94–96]. Shortly after,
NAi screen revealed that hnRNPLL has a key role in the activation-
nduced splicing in human T cells [97] and deﬁnes memory T
ell-speciﬁc forms of mRNA in mouse [98]. Although genome-wide
ublications with the latest technology are yet to be published,
here are indications that alternative splicing regulates the devel-
pment and function of different Th cell subtypes. For example,
everal alternatively spliced forms of regulatory T cell denoting
OXP3 have been observed in human, and alternative exon 2
as been shown to be essential for FOXP3-mediated inhibitory
nteraction with ROR and RORt, the factors promoting Th17
ell differentiation [99,100]. In addition, FOXP3 lacking exon 7
nduces Th17 cell polarization, and the expression level of this iso-
orm correlates with elevated IL17 production in Crohn’s disease
atients (Mailer et al., meeting abstract, The Journal of Immunology,
013:190,191.5).
The cellular protein-coding RNA pool is complemented with a
ariety of non-coding RNA molecules such as microRNAs (miRNA)
nd long non-coding RNAs (lncRNA) [101]. In addition to regulating
he endogenous gene expression the molecular machinery involved
n the biogenesis of these RNA molecules is now commonly
xploited in molecular biology providing novel research tools
specially important to studies performed with human cells as dis-
ussed above. miRNAs are about 21 nt long RNA molecules, which
epress gene expression posttranscriptionally by constraining the
nitiation of protein synthesis or inducing mRNA degradation [102].
ature miRNAs recognize the untranslated region (UTR) of their
arget mRNAs via imperfect base pairing. The requirement of only
artial complementarity enables several transcripts to be down-
egulated by a single type of miRNA. On the other hand, there
an be functional synergy of different miRNAs regulating the same
arget mRNA. Primary miRNA transcripts are processed into their
unctional forms by Dicer and Drosha RNAse III-like enzymes. The
rst indication that miRNAs regulate Th cell differentiation came
rom the studies with Dicer-deﬁcient mice, whose Th2 cells have
educed Gata3 expression and augmented IFNg production [103].
urthermore, miRNAs have been shown to be notably important for
uppressive activity of Treg cells as deletion of either Dicer or Drosha
eads to impaired Treg development and function [104–107]. In
ffector CD4+ cells the role of miRNAs seems to be moderate
nd related to ﬁne-tuning of Th cell phenotypes. Compared to
he changes in Th cell transcriptomes, the miRNomes of different
D4+ effector subtypes are much more similar further suggesting
heir role in adjusting the response. Nevertheless, human naïve
D4+, Th1, Th2 and Th17 cells have signature miRNAs which dis-
inguish these subtypes from each other. Moreover, miR-125b was
xperimentally shown to participate in the maintenance of the
aïve state of the CD4+ T cells [108]. The results showing that
iRNAs are needed for maintaining CD4+ cells undifferentiated is
n accordance with the ﬁnding that activation of T cells leads to
nhanced expression of mRNA isoforms with shorter 3′UTRs and
hus reduced number of miRNA target sites [109] and that miRNAmmunology 25 (2013) 282– 290 287
expression in general is reduced upon T cell activation [110]. In
mouse, miRNomes characteristic for Tfh and iTreg cells have also
been reported [111]. The authors of the human miRNome study
concluded that mouse and human miRNA pools were unexpect-
edly different and highlighted the importance of complementing
mouse studies with the ones performed with human cells [108].
However, there are not yet reports comparing miRNomes of mouse
and human Th subsets or during the differentiation process in a par-
allel experimental setup. The studies characterizing the function
of miRNAs in human Th cell differentiation are in general scarce
compared with mouse studies. To get a full overview on the topic,
interested readers are advised to explore an excellent review on
miRNAs in T cells [102].
A recent publication by Hu et al. catalogued the expression
of long intergenic non-coding RNAs (lincRNA), which are a sub-
group of lncRNAs, among mouse Th subtypes [112]. By overlaying
the data with the previously published DNA binding patterns of
STAT4, STAT6, TBX21 and GATA3, and by analyzing the lincRNA
expression in knock-out mice the study described that these mas-
ter regulators participate in deﬁning the Th cell subtype-speciﬁc
lincRNomes. Corresponding studies on human T cells have not yet
been published. However, the authors of a recent review imply
that they have unpublished RNA-seq results indicating that human
T cell differentiation is guided by selective expression of lncR-
NAs [113]. Previously, puriﬁed Th subtypes sorted from peripheral
blood have been shown to selectively express some lncRNAs in
a microarray-based expression analysis [114]. One reason for the
obscure expression of lncRNAs is that they are devoid of poly-A tail
more often than protein-coding genes [115]. Thus, proﬁling studies
using poly-A-selected RNA as a starting material may  lack infor-
mation of a signiﬁcant proportion of lncRNAs which are expressed
in a given cells. LncRNAs are also generally expressed at a lower
level than protein-coding genes [115]. Part of the functions of
lncRNAs is thought to be determined by their three-dimensional
structure, allowing low conservation of lncRNA sequences between
the species even when the function might be retained the same. In
addition, the expression of lncRNAs is highly tissue type and devel-
opmental stage-speciﬁc [116]. These facts highlight the importance
of studying the expression and function of lncRNAs relevant to
CD4+ cell differentiation with human cells in a kinetic fashion. Col-
lier et al. published the ﬁrst study highlighting the role of a lncRNA
in human Th cell polarization process last year. The study showed
that Tmevpg1 lncRNA is selectively expressed in Th1 cells and par-
ticipates in the induction of IFN expression [117]. Recently, NeST
aka Tmevpg1 was  shown to interact with WDR5, a core subunit of
an enzyme complex catalyzing the activating histone modiﬁcation,
and increase the presence of H3K4me3 mark in Ifn locus in mouse
CD8+ cells [118]. The role of Tmevpg1 in regulation of epigenetic
modiﬁcations in CD4+ cells remains to be investigated.
2. Concluding remarks
RNA-level measurements have been used to globally proﬁle the
signaling pathways devoted to controlling Th cell differentiation.
Most of the data has been gathered from mouse due to availabil-
ity of gene manipulation techniques not applicable to human cells.
However, as human and mouse have varying natural pathogens
and habitat, it can be reasonably expected that there are species-
speciﬁc adaptations in the immune system. Some of these have
already been reported [5–7], but more extensive comparative stud-
ies are needed to reveal the extent at which results acquired with
animal models can be extrapolated to human. Comparative stud-
ies can also be valuable in ﬁne-tuning experimental setups and
conditions of animal studies to better match the human biology.
In this review we have aimed at giving a view on the status of
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igh-throughput studies on gene expression regulation during
arly Th cell differentiation in human and pinpoint some of the
echanisms at which the knowledge is lacking behind compared
o the mouse studies.
As all gene regulatory mechanisms are highly intermingled,
haracterization of connectivity of different control levels will be
f great interest in the future. This not only requires that coding
nd non-coding fractions of the RNA along with histone and DNA
odiﬁcations will be analyzed together from the same samples,
ut also exploitation of novel techniques to reveal the underpin-
ing regulatory mechanisms. For example analysis of chromatin
ooping with ChIA-PET (chromatin interaction analysis by paired-
nd tag sequencing) offers a method of deﬁning three-dimensional
hromatin interactions in an unbiased high-throughput fashion
ithout a need to select the interactions to be studied before-
and [119]. Similarly, RNA–RNA and protein–RNA interactions can
e studied with applying crosslinking, complex precipitation and
igh-throughput sequencing [120,121]. In addition, miniaturizing
xperiments to a single-cell level will aid mechanistic studies, and
eveal the extent of variation in stochastic responses. In vivo an
xtreme response of only a few cells can be enough to trigger a
ignaling pathway with a strong impact on a system. These kinds
f responses can however be invisible when analyzing a cell popu-
ation revealing only an average response. Down-scaling of sample
aterial requirements will especially beneﬁt studies with human
ells with limited availability.
It is also important to remember that as far-reaching the
dvancements in sequencing technologies are, similar method-
logies are not available for proteins. Although RNA-level
easurement can be used to predict the protein expression level,
he correlation is not perfect. In addition, proteins are heavily
osttranslationally modiﬁed, which in many cases is the main
eterminant of the activity of the molecule. To complement this
rticle, a review by Lönnberg et al. [122] gives a sterling overview
n the usage of proteomics approaches in studies of T cell biol-
gy. In summary, although protein level measurements have been
pplied in the studies of T cell activation, the ﬁeld of Th cell differen-
iation is almost completely unexplored. Our group has done some
mportant openings in “omics” beyond transcriptomics in human
h cell differentiation. For example, our recently published articles
n IL4-induced nuclear proteome during the priming of human
h2 cells [123], and changes in the composition of lipidome in
esponse to T cell activation [124], are pioneering articles apply-
ng modern mass spectrometry to human Th cell biology. As the
nalysis methods keep on evolving and experts of different ﬁelds
ombine their efforts it is plausible to expect that Th cell biol-
gy, as having a central role in immune responses and as offering
n attracting model system for developmental biology, will be
sed as a playground at which different RNA and protein level
easurements will be incorporated into a comprehensive view of
n interplay of different regulatory mechanisms. This will be of
reat importance for translational research for Th cell-mediated
iseases.
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